Meiying Ning

Title: Meiying Ning: Innovator in Vaginal Drug Delivery Systems

Introduction

Meiying Ning is a prominent inventor based in Beijing, China. She has made significant contributions to the field of reproductive health through her innovative work in drug delivery systems. Her research focuses on improving therapeutic methods for luteal support, which is crucial for assisted reproduction and related medical conditions.

Latest Patents

Meiying Ning holds a patent for a vaginal sustained-release drug delivery system designed for luteal support. The patent, titled "Vaginal sustained-release drug delivery system for luteal support, method for preparation and use thereof," describes a progesterone depot-type vaginal ring. This ring features a bilayer structure consisting of a core layer made from a solid scaffold carrier of medical EVA, which contains the drug uniformly dispersed, and a film layer composed of medical EVA material without any drug. This innovative system significantly enhances therapeutic effects for conditions such as functional uterine bleeding and premenstrual syndrome due to luteal phase defects.

Career Highlights

Meiying Ning is affiliated with the National Research Institute for Family Planning, where she continues to advance her research in reproductive health. Her work has garnered attention for its potential to improve patient outcomes in assisted reproduction and related therapies.

Collaborations

Meiying has collaborated with notable colleagues, including Liangyu Xia and Xu Ma, who contribute to her research endeavors. Their combined expertise enhances the development and application of innovative solutions in reproductive health.

Conclusion

Meiying Ning's contributions to the field of vaginal drug delivery systems represent a significant advancement in reproductive health. Her innovative patent and ongoing research efforts continue to pave the way for improved therapeutic options for women facing luteal phase defects.